购物车
全部删除
您的购物车当前为空
QStatin 是一种弧菌物种群体感应的选择性SmcR 抑制剂,EC50值为 208.9 nM。与 SmcR 紧密结合并改变了蛋白质的柔韧性,从而改变了其转录调控活性。并减弱其在水生宿主中的毒力。它可用于水产养殖的可持续性抗弧菌病药物。


为众多的药物研发团队赋能,
让新药发现更简单!
QStatin 是一种弧菌物种群体感应的选择性SmcR 抑制剂,EC50值为 208.9 nM。与 SmcR 紧密结合并改变了蛋白质的柔韧性,从而改变了其转录调控活性。并减弱其在水生宿主中的毒力。它可用于水产养殖的可持续性抗弧菌病药物。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 119 | 现货 | |
| 5 mg | ¥ 278 | 现货 | |
| 10 mg | ¥ 449 | 现货 | |
| 25 mg | ¥ 833 | 现货 | |
| 50 mg | ¥ 1,180 | 现货 | |
| 100 mg | ¥ 1,660 | 现货 | |
| 200 mg | ¥ 2,330 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 306 | 现货 |
Qstatin 相关产品
| 产品描述 | QStatin, a Selective Inhibitor of Quorum Sensing in Vibrio Species( SmcR with an EC50 of 208.9 nM). |
| 靶点活性 | SmcR:208.9 nM(EC50) |
| 体外活性 | Qstatin 对SmcR活性的抑制作用最强,而且对V. vulnificus的生长抑制不显著。通过测量不同浓度的QStatin下V. vulnificus WT (pBB1)的RLU水平来评估SmcR活性,结果显示QStatin的半最大有效浓度(EC50)为208.9 nM。 |
| 细胞实验 | The plasmid pBB1 carrying the LuxRVh homologue-activated lux operon was conjugally transferred into the V. vulnificus wild-type (WT) strain, the ΔsmcR mutant, or the ΔluxO mutant. These V. vulnificus reporter strains were grown overnight, diluted 1:1,000 in fresh LBS, and treated with hit molecules. RLU values were calculated every hour. To determine the EC50, QStatin (10^?12 to 10^?4 M) or 2% DMSO as a control was added to the V. vulnificus WT reporter strain and RLU was measured after 5 h. The percentage of SmcR activity of the sample at a given concentration of QStatin was determined using the following equation: percent SmcR activity = sample RLU/control RLU × 100. The EC50 of QStatin (the concentration reducing the SmcR activity to 50%) was calculated from a plot of the percentages of SmcR activity versus QStatin concentrations using GraphPad Prism 6.0. |
| 分子量 | 293.16 |
| 分子式 | C7H5BrN2O2S2 |
| CAS No. | 902688-24-8 |
| Smiles | Brc1ccc(s1)S(=O)(=O)n1cccn1 |
| 密度 | 1.93 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 83.33 mg/mL (284.25 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (11.26 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容